What the work claims
Cell-mediated immunity is a distinct branch of immunity rooted in cellular activity—not antibodies—and serves specific biological roles: defence against intracellular pathogens, cancer surveillance, and transplant rejection.
How it was done
Cell-mediated immunity was defined by conceptual distinction—not experiment—against humoral immunity in the late 19th century. It was identified as an antibody-independent response involving phagocytes, cytotoxic T cells, and cytokines.
What holds up
The definition holds: cell-mediated immunity is antibody-independent. Its components—phagocyte activation, cytotoxic T cells, cytokine release—are stated as involved. Its targets hold: virus-infected cells, intracellular bacteria, fungi, protozoa, cancers, and transplanted tissue.
What does not
The material does not establish a mechanism, timeline of experimental validation, molecular pathway, error margin, sample size, or in vivo measurement method. It does not quantify efficacy, compare it to humoral immunity, or cite a discovery date or discoverer.
Why it matters beyond the lab
It matters because transplant rejection, antiviral immunity, and cancer immunotherapy all depend on this axis—not antibodies. Clinically, it separates vaccine design, immunosuppression, and diagnostic logic.
Is it worth your time
Yes—if you need to distinguish immune mechanisms in clinical, therapeutic or immunological contexts. It is foundational, not novel.





